AIRBUS - 2020 Financial Statement

2. Notes to the IFRS Consolidated Financial Statements / 2.6 Employees Costs and Benefits

33.2 ESOP In 2020 and 2019, the Board of Directors approved a new ESOP scheme. Eligible employees were able to purchase a fixed number of previously unissued shares at fair market value (5, 10, 15, 30 or 100 shares in 2020, 5, 15, 30, 50 or 100 shares in 2019). The Company matched each fixed number of shares with a number of the Company free shares based on a determined ratio (4, 6, 7, 10 and 25 free shares, respectively in 2020, versus 4, 7, 10, 13 and 25 free shares, respectively in 2019). During a custody period of at least one year, employees are restricted from selling the shares, but have the right to receive all dividends paid. Employees who directly purchased the Airbus SE shares have, in addition, the ability to vote at the Annual Shareholder Meetings. The subscription price was equal to the closing price at the Paris stock exchange on 12 February 2020 (2019: 13 February 2019)

and amounted to €136.60 (2019: €104.38). Investing through a mutual fund led to a price which corresponds to the average price at the Paris stock exchange during the 20 trading days immediately preceding 12 February 2020 (2019: 13 February 2019), resulting in a price of €136.00 (2019: €97.76). In 2020, the Company issued and sold 671,640 ordinary shares (2019: 1,332,840) with a nominal value of €1.00 each. In 2020, the Company issued and distributed 304,515 matching ordinary shares (2019: 451,452) with a nominal value of €1.00 each. Compensation expense (excluding social security contributions) of €34 million (2019: €47 million) was recognised in connection with ESOP in 2020.

34. Remuneration

34.1 Remuneration – Executive Committee The Company’s key management personnel consists of Members of the Executive Committee and Non-Executive Board Members. The Chief Executive Officer (“CEO”), who chairs the Executive Committee, is the sole Executive Board Member. The annual remuneration and related compensation costs of the key management personnel as expensed in the respective year can be summarised as follows:

2020

2019

(In € million)

Executive Committee, including Executive Board Member Salaries and other short-term benefits (including bonuses)

16.1

16.5

4.8

1.1

Post-employment benefit costs

1.0

10.5

Share-based remuneration (“LTIP award”, including associated hedge result)

0

(0.4)

Termination benefits (1)

2

0.5

0.4

Other benefits

4.7

4.5

Social charges (2)

Non-Executive Board Members Short-term benefits (including social charges)

2.2

2.4

Total expense recognised

29.3

35.0

(1) 2019 Termination benefits include the adjustment of the estimated amount accounted for in 2018 based on last information available and applicable law. (2) Costs of benefits provided through applicable mandatory collective and social security plans are accounted for among social charges.

Salaries and Other Short-Term Benefits (Including Bonuses) The amount of bonuses is based on estimated performance achievement as at the balance sheet date and difference between previous year estimation and actual pay-out in the current year. Outstanding short-term benefits (bonuses) at year-end 2020 for Executive Committee Members based on estimated performance achievement at year-end was €7.7 million (2019: €7.5 million). Post-Employment and Other Long-Term Benefits The post-employment and other long-term benefits defined obligation for the Executive Committee, including the CEO, amounted to €32.8 million at 31 December 2020 (2019: €29.8 million). The disclosed post-employment and other long-term benefits reflect the total outstanding balance for all Executive Committee Members in charge at the end of the respective balance sheet date. In 2019, the defined benefit plan in France was frozen, leading to a remeasurement of past service cost recognised as a profit in the Profit & Loss which mainly explains the difference in the Post-employment benefits costs between 2020 (€4.8 million) and 2019 (€1.1 million).

55

Airbus / Financial Statements 2020